Medico Remedies Ltd Reports Rs 131 Crore Profit for FY26

Medico Remedies Ltd has announced its audited standalone financial results for the fiscal year ended March 31, 2026. The company achieved a net profit of Rs 1,311.52 lakh (approximately Rs 131.15 crore) on total income of Rs 21,231.08 lakh for the full year.

Full-Year and Fourth Quarter Results

The Board of Directors approved these financial results on May 21, 2026. For the fourth quarter of FY26, ending March 31, 2026, the company reported a net profit of Rs 585.66 lakh, with total income at Rs 5,968.16 lakh. The financial statements received an unmodified opinion from auditors M/s. Shah Shroff & Associates, indicating confidence in the company's financial reporting. Reports on Management Discussion and Analysis, Corporate Governance, and the Board's Report for FY26 were also approved.

Financial Performance Overview

These results offer shareholders a clear view of Medico Remedies' financial performance over the past fiscal year, detailing profitability and income generation. The company's total assets stood at Rs 15,340.33 lakh, with total equity at Rs 7,547.45 lakh as of March 31, 2026.

Business Context

Medico Remedies Ltd operates in the pharmaceutical sector, focusing on manufacturing and exporting pharmaceutical products. The company has been working to expand its product range and market presence.

Investor Outlook

With the disclosure of these financial results, investors can make more informed decisions. While the full-year performance shows a profit, investors will closely monitor expense management and revenue growth strategies for the upcoming fiscal year, especially considering that expenses for FY26 were Rs 19,425.12 lakh.